"India's biotechnology economy can approach $100 billion in 2025 if the right policies are put in place, giving industry the required stimulation," he said
India has the potential to develop an antidote to Covid-19
Kilpest India, one of the companies that have received ICMR's approval to produce RT-PCR kits for Covid-19 testing, has seen its share price more than double since April 1
Mankind became the first Indian and second global company to develop a dydrogesterone containing drug for treatment of pregnancy-related complications
Biocon Biologics, through its partner Mylan, has commercialised three of its co-developed biosimilars in developed markets like the US, Canada, the European Union and Australia.
Of the 3,000 entrepreneurs who've started biotech firms in the past 5 years, a third are women
Draft policy provides land on priority for projects, 33% subsidy on plant & machinery; power cost reimbursed at a rupee per unit
Currently, the project is through for construction at a budget of around Rs 100 crore in the first phase